Textron Inc.
79.89USD
+0.3500 (+0.44%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.52▼ | $1.66 | 0 | 15 |
| Next quarter | $1.88▲ | $1.87 | 6 | 8 |
| Current year | $6.46▼ | $6.51 | 2 | 10 |
| Next year | $7.26▼ | $7.3 | 5 | 9 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $1.55 | $1.62 | +0.07 (+4.8%) |
| 2026-03-31 | $1.3 | $1.45 | +0.15 (+11.3%) |
| 2025-12-31 | $1.7 | $1.73 | +0.03 (+1.5%) |
| 2025-09-30 | $1.46 | $1.55 | +0.09 (+6.4%) |
247 ratings from 27 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Hold | $115 $105 | Jul 13, 2026 |
| JP Morgan | Maintained | Neutral | $90 $105 | May 4, 2026 |
| UBS | Maintained | Neutral | $99 $100 | May 4, 2026 |
| Jefferies | Maintained | Buy | $115 $110 | Apr 7, 2026 |
| Citigroup | Maintained | Neutral | $97 $99 | Apr 2, 2026 |
| Wells Fargo | Initiated | Equal-Weight | $92 | Apr 1, 2026 |
| Bernstein | Maintained | Market Perform | $94 $108 | Feb 19, 2026 |
| Jefferies | Maintained | Buy | $115 $110 | Feb 2, 2026 |
| JP Morgan | Maintained | Neutral | $88 $90 | Jan 29, 2026 |
| Citigroup | Maintained | Neutral | $107 $97 | Jan 29, 2026 |
| UBS | Maintained | Neutral | $89 $99 | Jan 15, 2026 |
| Citigroup | Maintained | Neutral | $91 $107 | Jan 13, 2026 |
| Citigroup | Initiated | Neutral | $91 | Dec 12, 2025 |
| Freedom Broker | Maintained | Buy | $92 $93 | Oct 29, 2025 |
| JP Morgan | Maintained | Neutral | $90 $88 | Oct 27, 2025 |
| TD Cowen | Maintained | Hold | $95 $90 | Oct 24, 2025 |
| UBS | Maintained | Neutral | $92 $89 | Oct 24, 2025 |
| Barclays | Maintained | Overweight | $95 $105 | Jul 29, 2025 |
| UBS | Upgraded from Sell | Neutral | $73 $88 | Jul 28, 2025 |
| Susquehanna | Maintained | Positive | $90 $95 | Jul 25, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $71 $86 | Jul 17, 2025 |
| Goldman Sachs | Downgraded from Buy | Neutral | $95 $85 | Jul 1, 2025 |
| Jefferies | Maintained | Buy | $85 $95 | Jun 12, 2025 |
| UBS | Maintained | Sell | $62 $63 | Apr 28, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $82 $71 | Apr 11, 2025 |
50 filings from 16 insiders · 10 buy / 1 sell over 6m
Officers and directors of TXT, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| CLARK RONALD KERRYDirector | Sell | 2.5k | $93.09 | $234k | May 6, 2026 |
| KENNEDY THOMAS ADirector | Buy | 10.3k | $95.98 | $989k | May 1, 2026 |
| KENNEDY THOMAS ADirector | Grant | 2.1k | — | — | Apr 29, 2026 |
| JAMES DEBORAH LEEDirector | Grant | 2.1k | — | — | Apr 29, 2026 |
| MIONIS ROBERT ANDREWDirector | Grant | 2.1k | — | — | Apr 29, 2026 |
| GARRETT MICHAEL XDirector | Grant | 2.1k | — | — | Apr 29, 2026 |
| MENDEZ ECHEVARRIA MARIA CRISTINADirector | Grant | 2.1k | — | — | Apr 29, 2026 |
| AMBROSE RICHARD F.Director | Grant | 2.1k | — | — | Apr 29, 2026 |
| ZUBER MARIA T.Director | Grant | 2.1k | — | — | Apr 29, 2026 |
| CLARK RONALD KERRYDirector | Grant | 2.1k | — | — | Apr 29, 2026 |
| NOWELL LIONEL L IIIDirector | Grant | 2.1k | — | — | Apr 29, 2026 |
| DUFFY JULIE GULLENOfficer | Grant | 3.9k | — | — | Feb 27, 2026 |
| ATHERTON LISA MChief Executive Officer | Grant | 27.1k | — | — | Feb 27, 2026 |
| ROSENBERG DAVID MATHEWChief Financial Officer | Grant | 6.1k | — | — | Feb 27, 2026 |
| LUPONE E ROBERTGeneral Counsel | Grant | 5.6k | — | — | Feb 27, 2026 |
| DONNELLY SCOTT COfficer and Director | Grant | 13.0k | — | — | Feb 27, 2026 |
| BAMFORD MARK SOfficer | Grant | 1.3k | — | — | Feb 27, 2026 |
| LUPONE E ROBERTGeneral Counsel | Exercise | 28.1k | $49.58 | $1.39M | Feb 17, 2026 |
| BAMFORD MARK SOfficer | Exercise | 17.8k | $40.60 | $854k | Feb 17, 2026 |
| BAMFORD MARK SOfficer | Sell | 29.3k | $97.96 | $2.88M | Feb 17, 2026 |
No analyst notes on TXT yet.
Analyst Ratings
15 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 6 | 9 | 0 | 0 | Hold2.50 |
| 1 mo ago | 1 | 6 | 9 | 0 | 0 | Hold2.50 |
| 2 mo ago | 1 | 6 | 10 | 0 | 0 | Hold2.53 |
| 3 mo ago | 0 | 6 | 11 | 0 | 0 | Hold2.65 |